Best Health Care Grants in Wisconsin

The Patient-Centered Outcomes Research Institute (PCORI) will announce funding for patient-centered comparative clinical effectiveness research (CER) studies focusing on rare diseases. This initiative encourages collaboration and aims to fill critical research gaps affecting approximately 30 million Americans with rare diseases. Applications can request up to $12 million over five years, including coverage for patient care costs. This funding opportunity is set to open on August 12, 2025, with a focus on addressing pressing patient-centered CER questions.

The PCORI Engagement Award: Capacity Building aims to enhance the capacity of patients and stakeholders in patient-centered comparative clinical effectiveness research (CER). Projects can last up to two years with funding up to $300,000. Successful proposals will demonstrate understanding of CER, community engagement, and commitment from stakeholders. The initiative encourages the use of existing tools and resources to foster patient involvement in research processes, aligning with national health priorities and addressing pressing healthcare issues.

The Engagement Award: Dissemination Initiative, part of the Eugene Washington PCORI program, focuses on promoting active involvement of patients, families, and caregivers in health research. It supports organizations in effectively communicating PCORI-funded research findings to their audiences, enhancing understanding and application in healthcare decisions. Projects must demonstrate stakeholder engagement and a solid evaluation plan. This initiative aims to bridge the gap between research and community application, ensuring impactful dissemination of critical health information.

The Craft Archive Fellowship supports archival research on underrepresented craft histories in the U.S., including feminist, queer, Black, Indigenous, and other marginalized communities. It offers a $5,000 stipend for scholars and artists to conduct research in chosen archives, encouraging innovative approaches. Participants will present their findings in a virtual program, and their work will be published in Hyperallergic, broadening accessibility and awareness of vital craft research.

The CAA Professional Development Fellowship in Art History provides crucial support for recent PhD graduates and scholars from multicultural and underrepresented backgrounds in the field of art history. This fellowship awards $10,000 to assist with job-search expenses, image licensing, and publishing costs. Additionally, each recipient gains a one-year CAA membership and free registration for the upcoming Annual Conference, encouraging diverse voices in the art community to flourish.

The CAA Professional Development Fellowship in Visual Arts offers a $10,000 grant to support MFA students and artists from underrepresented groups. This fellowship aids in job-search expenses or purchasing materials for their studio practice. Recipients also receive a one-year CAA membership and free registration to the Annual Conference. Honorable Mentions will also receive membership and conference registration. This initiative promotes diversity and provides crucial support to emerging artists in their professional journey.

The NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) aims to foster the development of promising audiologists through comprehensive postdoctoral research experiences. This funding opportunity supports individuals in biomedical, behavioral, or clinical sciences, helping them become independent researchers. The deadlines for applications span from June 2024 to May 2027, ensuring ample time for preparation and submission.

The NIDCD Mentored Career Development Award supports postdoctoral Au.D./Ph.D. audiologists in their research and career development. This grant aims to foster independence in scientific health-related research relevant to the NIDCD's mission. Key deadlines for applications span from June 2024 to May 2027, providing numerous opportunities for eligible candidates to secure funding and advance their careers in the biomedical and clinical sciences.

The NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) aims to support the career development of promising audiologists through rigorous postdoctoral research in biomedical, behavioral, or clinical sciences. This initiative encourages independent investigation in health-related research relevant to NIDCD's mission. Applications are due on various dates, with the next deadline on June 13, 2024, providing opportunities for advancing research in audiology and related fields.

The New Foundation for Art History (NFAH) offers innovative non-residential fellowships for mid-career scholars, emphasizing excellence in research across various art eras and cultures. Established in 2019, NFAH aims to support scholars from U.S. institutions, particularly those at smaller schools, with grants up to $50,000 to aid in their research endeavors. The initiative promotes diversity and equity within the field, ensuring that scholars receive the resources they need to thrive.

The New Foundation for Art History (NFAH) offers Fellowships for Contingent Faculty to address the growing reliance on contingent positions in art history. Launched in 2019, these fellowships provide $10,000 to $15,000 for each summer, up to $45,000 over three years. By accommodating the unique schedules of contingent faculty, NFAH aims to support research and publication efforts, facilitating career advancement and promoting equity within the discipline.

The New Foundation for Art History (NFAH), established in 2019, aims to innovate within the art history field by addressing gaps left by other institutions. Offering five publication subvention grants of $1,000 to $5,000, NFAH prioritizes applications from U.S. scholars, especially those in underrepresented areas. With a commitment to diversity and equity, NFAH adapts its initiatives based on community feedback, fostering excellence in research and publication.

The ARRL Foundation offers grants for amateur radio projects, focusing on education, licensing, and community support in the U.S. Organizations can apply three times a year for funding, with a preference for youth initiatives and sustainable projects. Notably, grants are awarded exclusively to organizations, not individuals, and emergency communication equipment requests are ineligible. This funding aims to enhance amateur radio's public service and technological advocacy.

Myasthenia Gravis Rare Disease Network (MGNet)

The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.

Diseases Studied

Myasthenia Gravis (MG) and its subtypes:

• Early-onset acetylcholine receptor (AChR) antibody (Ab) positive MG, which primarily affects women
• Late-onset AChR Ab positive MG with a disease bias towards men
• Paraneoplastic thymoma-associated MG
• Muscle specific kinase (MuSK) Ab positive
• AChR/MuSK antibody negative MG

Goals, Mission, & Vision

The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:

• Improve the tools scientists and doctors have for performing clinical trials through rigorous monitoring of patients over time and evaluate better measures of how patients are doing.
• Identify objective measures (biomarkers) to show how the disease is responding to treatment and better predict treatment response or side effects, to improve the design of clinical trials and care of patients in clinical practice.
• Enhance the education of young investigators focusing their careers on rare diseases and specifically MG.
• Improve the awareness of scientists, physicians, and the public regarding the unique needs of patients with MG through training of clinician scientists and engagement of the patient and scientific communities in clinical research and therapeutic development.

Scholar Awards

Objectives

There is a critical need for investigators prepared to conduct clinical and translational research in myasthenia gravis (MG). The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.

Award Description

The MGNet Scholar Program provides mentored research training to prepare Scholars for an independent research career in the field of MG. The MGNet Scholar Program is 1 year in duration and selected Scholars receive up to $100,000 to support salary, research costs and didactics with potential for renewal. The program will provide an additional $3,000 to travel to MGNet sites to learn specific skills and/or to scientific meeting(s) to present the results of their research. If available for renewal, the program requires approval after interim report and is contingent on demonstration of adequate progress on the research and career development plan. Indirect costs are not allowed. Scholars are encouraged to transition to NIH (e.g., K award), departmental, or private foundation support for their research and further career development.Research must constitute at least 50% of each Scholar’s professional effort. Each Scholar must form a 2-3-member advisory committee to include a primary mentor, an additional clinician investigator or collaborator, and a MGNet faculty sponsor. The advisory committee will meet with the Scholar at least quarterly to review progress and each Scholar will develop an individual academic career development plan and renew it with the committee at least every 6 months.

The Michael Aurbach Fellowship for Excellence in Visual Art, awarded by the College Art Association, supports artist members with an MFA or equivalent who teach studio classes. This fellowship provides a $7,500 award and conference registration to a qualifying artist, focusing on their artistic work rather than a proposal. It aims to recognize and empower visual arts professionals in academia.

Myasthenia Gravis Rare Disease Network (MGNet)

The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.

Diseases Studied

Myasthenia Gravis (MG) and its subtypes:

• Early-onset acetylcholine receptor (AChR) antibody (Ab) positive MG, which primarily affects women
• Late-onset AChR Ab positive MG with a disease bias towards men
• Paraneoplastic thymoma-associated MG
• Muscle specific kinase (MuSK) Ab positive
• AChR/MuSK antibody negative MG

Goals, Mission, & Vision

The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:

• Improve the tools scientists and doctors have for performing clinical trials through rigorous monitoring of patients over time and evaluate better measures of how patients are doing.
• Identify objective measures (biomarkers) to show how the disease is responding to treatment and better predict treatment response or side effects, to improve the design of clinical trials and care of patients in clinical practice.
• Enhance the education of young investigators focusing their careers on rare diseases and specifically MG.
• Improve the awareness of scientists, physicians, and the public regarding the unique needs of patients with MG through training of clinician scientists and engagement of the patient and scientific communities in clinical research and therapeutic development.

Pilot and Feasibility Grants

Objectives

MGNet, a NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Conquer MG, is seeking proposals for highly innovative investigations in early stages of development.

The priorities of the Pilot Grant Program are:

• Identification treatment responsive biomarkers
• Assess clinical measures and improve that enhance clinical trial readiness
• Evaluation of therapeutic interventions for one or more of the five distinct sub-types of MG

Pilot studies must be designed to access the resources of MGNet and focused on clinical and translational research, including fulfilling the definition of clinical and translational research and exclusion of animal studies.

Funding

The MGNet expects to fund up to two grants, each at a level of $75,000 (IDCs will be limited to 10% and included in the $75,000). Projects will be funded for 12 months. Selection among the applications received will be based on the recommendations of a review committee. A grant may be renewed for an additional one year with approval of interim report by the same review process and availability of funds. Demonstration of fulfillment of initial aims and justification for additional funding will be required. The request will be required a minimum of three months prior to the initial funding period completion.

The NewSchools: Teaching Reimagined Grant offers a unique funding opportunity of $150,000 to $250,000 for innovative ideas aimed at reimagining the role of educators and enhancing student outcomes. With a focus on leveraging generative AI, the grant supports early-stage organizations and initiatives that prioritize diverse teaching strategies and community involvement. The application deadline is January 8, 2026, with a priority deadline of December 1, 2025, for updates on eligibility.

The NIH Pathway to Independence Award (K99/R00) supports the transition of postdoctoral researchers to independent faculty positions. It aims to enhance the number of talented NIH-supported investigators by providing funding during their transition to independent research careers. Key deadlines for applications are set for various dates through 2027. This program is crucial for developing a strong cohort of new independent researchers, fostering innovation in health-related fields.

The NIH Pathway to Independence Award (K99/R00) program is designed to support promising postdoctoral researchers in transitioning to independent faculty positions. This initiative aims to maintain a strong cohort of talented investigators by providing independent NIH research funding during this critical phase. Key application deadlines span from June 2024 to February 2027, encouraging applications from diverse fields, including AIDS-related research.

The Arthritis Foundation is inviting proposals for research aimed at understanding and predicting the progression of rheumatoid arthritis (RA). This includes identifying risk factors and mechanisms to prevent or slow the onset of RA. The program encourages innovative studies from early and mid-career investigators affiliated with U.S. institutions, with funding options that support both pilot and large research awards. The ultimate goal is to enhance outcomes for RA patients.

The Basic Needs Giving Partnership provides single-year grants to support organizations in Northeast Wisconsin that are addressing the root causes of poverty. Their focus is on collaborative initiatives in areas such as early care and education, housing access, mental health, and substance use. By partnering with local communities, they aim to foster equity and enhance economic well-being, while also disrupting systemic barriers that perpetuate poverty.

The Jack and Fay Netchin Medical Student Summer Fellowships, offered by the American Brain Tumor Association, provide $3,000 grants to medical students eager to engage in brain tumor research under the guidance of experienced mentors. This initiative aims to inspire the next generation of neuro-oncology researchers, fostering a deeper commitment to advancing treatment and understanding of brain tumors for those affected by this challenging diagnosis.

The Morton B. Duggan, Jr. Memorial Education Recognition Award, provided by the American Respiratory Care Foundation, honors a student enrolled in an accredited respiratory care program. This award, which can reach up to $1,000, includes a certificate of recognition, travel expenses, and registration for AARC Congress. Eligible applicants must verify their enrollment and GPA, and provide letters of recommendation. Preference is given to candidates from Georgia and South Carolina.

The Jimmy A. Young Memorial Education Recognition Award, offered by the American Respiratory Care Foundation, honors contributions to respiratory care education. Up to $1,000 is available for students enrolled in accredited respiratory care programs, provided they meet GPA requirements and submit necessary recommendations. This award includes a certificate, airfare, lodging, and registration for the AARC Congress, aiming to support deserving candidates in their educational pursuits.

The NIH Midcareer Investigator Award in Patient-Oriented Research (K24) supports mid-career health professionals by providing protected time for patient-oriented research and mentorship to clinical residents, fellows, and junior faculty. The program aims to enhance research capabilities and promote career development in the field of patient-oriented research. Key deadlines for applications include June 12, 2024, and October 12, 2024, among others, ensuring opportunities for renewal and resubmission.

The NIH Midcareer Investigator Award in Patient-Oriented Research (K24) aims to support mid-career health professionals in conducting patient-oriented research while mentoring clinical residents and junior faculty. This grant offers protected time for research, ensuring participants can focus on impactful studies and foster the next generation of clinical researchers. Key deadlines for applications range from June 2024 to February 2027, with specific dates for standard, renewal, and AIDS-related submissions.

The NIH Midcareer Investigator Award in Patient-Oriented Research (K24) supports mid-career health-professional doctorates by providing protected time for patient-oriented research (POR). This grant also enables recipients to serve as research mentors for clinical residents, fellows, and junior faculty. Key deadlines for applications span from June 2024 to February 2027, ensuring ample opportunities for interested applicants to engage in impactful research and mentoring.